{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:40:05Z","timestamp":1756309205934,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,12,19]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>Serotonin syndrome (SS) is an iatrogenic, drug-induced clinical syndrome caused by an increase in the intrasynaptic concentration of serotonin. Serotonin plays a significant role in the pathophysiology of migraines. Upregulation of 5-HT2A receptors is found in medication-overuse headache (MOH). Several migraine medications, both preventative and abortive drugs, act on serotonin receptors. We report two patients with chronic migraine who developed MOH. Besides headache, patients had frequent attacks of dizziness, restlessness, irritability, insomnia, excessive sweating, abdominal discomforts and tremors. These symptoms were suggestive of withdrawal headache. However, on physical examinations, we elicited hyperreflexia, hypertonia, clonus, tachycardia, hypertension, mydriasis and hyperactive bowel sound. Both patients also met the criteria for SS. Cyproheptadine was started. All features, including headaches, got better after cyproheptadine administration within 24 hours. In 7\u2009days, there was practically total improvement. Both patients continued to take cyproheptadine as a preventative medicine, and migraine frequency was under control.<\/jats:p>","DOI":"10.1136\/bcr-2023-256464","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:30:39Z","timestamp":1704846639000},"page":"e256464","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Medication-overuse headache overlapping with serotonin syndrome"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-904X","authenticated-orcid":false,"given":"Sanjay","family":"Prakash","sequence":"first","affiliation":[{"name":"Neurolgy, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Patel","sequence":"additional","affiliation":[{"name":"Neurolgy, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetsi Sudhir","family":"Shah","sequence":"additional","affiliation":[{"name":"Neurolgy, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"2025082708145445000_17.1.e256464.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867"},{"key":"2025082708145445000_17.1.e256464.2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413495968"},{"key":"2025082708145445000_17.1.e256464.3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0333102416640501","article-title":"Serotonergic mechanisms in the migraine brain\u2013a systematic review","volume":"37","author":"Deen","year":"2017","journal-title":"Cephalalgia"},{"key":"2025082708145445000_17.1.e256464.4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.seizure.2021.06.004","article-title":"Antiepileptic drugs and serotonin syndrome-a systematic review of case series and case reports","volume":"91","author":"Prakash","year":"2021","journal-title":"Seizure"},{"key":"2025082708145445000_17.1.e256464.5","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109"},{"key":"2025082708145445000_17.1.e256464.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00824-5"},{"key":"2025082708145445000_17.1.e256464.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x"},{"key":"2025082708145445000_17.1.e256464.8","first-page":"223","article-title":"A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis","volume":"48","author":"Rao","year":"2000","journal-title":"Neurol India"},{"key":"2025082708145445000_17.1.e256464.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"key":"2025082708145445000_17.1.e256464.10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5498\/wjp.v11.i4.124","article-title":"Chronic serotonin syndrome: a retrospective study","volume":"11","author":"Prakash","year":"2021","journal-title":"World J Psychiatry"},{"key":"2025082708145445000_17.1.e256464.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000177642.89888.85"},{"key":"2025082708145445000_17.1.e256464.12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2016-1839","article-title":"The diverse metabolic roles of peripheral serotonin","volume":"158","author":"Martin","year":"2017","journal-title":"Endocrinology"},{"key":"2025082708145445000_17.1.e256464.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02142.x"},{"key":"2025082708145445000_17.1.e256464.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1994.hed3401008.x"},{"key":"2025082708145445000_17.1.e256464.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3807534.x"},{"key":"2025082708145445000_17.1.e256464.16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/JPR.S283734","article-title":"Involvement of 5-hydroxytryptamine receptor 2A in the pathophysiology of medication-overuse headache","volume":"14","author":"Zheng","year":"2021","journal-title":"J Pain Res"},{"key":"2025082708145445000_17.1.e256464.17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/aian.AIAN_344_18","article-title":"Refining the clinical features of serotonin syndrome: a prospective observational study of 45 patients","volume":"22","author":"Prakash","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"2025082708145445000_17.1.e256464.18","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199810040-00005"},{"key":"2025082708145445000_17.1.e256464.19","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17204"},{"key":"2025082708145445000_17.1.e256464.20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123 (Pt 1)","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"key":"2025082708145445000_17.1.e256464.21","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-021-01343-2","article-title":"Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine","volume":"22","author":"Tassorelli","year":"2021","journal-title":"J Headache Pain"},{"key":"2025082708145445000_17.1.e256464.22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4274\/tjps.galenos.2018.35403","article-title":"The contribution of serotonergic receptors and nitric oxide systems in the analgesic effect of acetaminophen: an overview of the last decade","volume":"17","author":"Hamurtekin","year":"2020","journal-title":"Turk J Pharm Sci"},{"key":"2025082708145445000_17.1.e256464.23","doi-asserted-by":"crossref","DOI":"10.1515\/jcim-2019-0016","article-title":"Celecoxib, ibuprofen, and indomethacin alleviate depression-like behavior induced by interferon-Alfa in mice","volume":"17","author":"Mesripour","year":"2019","journal-title":"J Complement Integr Med"},{"key":"2025082708145445000_17.1.e256464.24","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000287"},{"key":"2025082708145445000_17.1.e256464.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.02.006"},{"key":"2025082708145445000_17.1.e256464.26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4103\/0366-6999.178957","article-title":"Tramadol pill alone may cause serotonin syndrome","volume":"129","author":"Aminiahidashti","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"2025082708145445000_17.1.e256464.27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ynpai.2018.01.004","article-title":"Involvement of 5-Ht1A\/1B receptors in the antinociceptive effect of paracetamol in the rat formalin test","volume":"3","author":"Roca-Vinardell","year":"2018","journal-title":"Neurobiol Pain"},{"key":"2025082708145445000_17.1.e256464.28","doi-asserted-by":"publisher","DOI":"10.1177\/026988119901300111"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-256464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:15:04Z","timestamp":1756307704000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-256464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,4]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/bcr-2023-256464"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-256464","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}